For the full presentation, downloadable slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/BRK865. CME/MOC/NCPD/AAPA credit will be available until April 29, 2026.
Exploring the Promise of Biomarkers and ATTs in Diagnosing and Treating Early Symptomatic Alzheimer’s Disease: Key Takeaways From AD/PD 2025 and AAN 2025
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Lilly.
Disclosure information is available at the beginning of the video presentation
View all episodes
By PVI, PeerView Institute for Medical Education
4.3
1010 ratings
For the full presentation, downloadable slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/BRK865. CME/MOC/NCPD/AAPA credit will be available until April 29, 2026.
Exploring the Promise of Biomarkers and ATTs in Diagnosing and Treating Early Symptomatic Alzheimer’s Disease: Key Takeaways From AD/PD 2025 and AAN 2025
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Lilly.
Disclosure information is available at the beginning of the video presentation
5 Listeners
3 Listeners
3 Listeners
5 Listeners
27 Listeners
10 Listeners
3 Listeners
2 Listeners
4 Listeners
3 Listeners
288 Listeners
3 Listeners
5 Listeners
5 Listeners
2 Listeners
129 Listeners
0 Listeners
9 Listeners
2 Listeners
15,063 Listeners
50 Listeners
10 Listeners
44 Listeners
2 Listeners
493 Listeners
111,761 Listeners
56,180 Listeners
1,090 Listeners
7,910 Listeners
289 Listeners
556 Listeners
12,918 Listeners
28,304 Listeners
112 Listeners